COVID-19疫情期间神经外科肿瘤门诊远程医疗的经验与未来启示
本文总结了多机构在COVID-19疫情期间对神经肿瘤外科门诊患者实施远程医疗的经验,分析了远程医疗应用于神经肿瘤门诊的益处、局限及必要考量。文章逐环节探讨了医生、患者、排程、预就诊、影像和体格检查等方面的远程医疗特定注意事项。结论认为远程医疗是未来神经肿瘤门诊医疗有力且可能优先的工具。
要点
- 远程医疗在神经肿瘤门诊中兼具优势与局限。
- 需针对预约各环节制定远程医疗特定考量。
- 远程医疗可能成为未来神经肿瘤门诊优先工具。
核心结论
- 远程医疗在COVID-19疫情期间被推至突出地位,是未来神经肿瘤门诊医疗有力且可能优先的工具。
研究设计与样本
- 多机构经验总结,描述神经肿瘤外科门诊患者远程医疗的潜在益处、陷阱及必要考量。
主要发现
- 远程医疗纳入神经肿瘤门诊医疗存在局限与优势。
- 需对预约各步骤和利益相关方(医生、患者、排程、预就诊、影像、体格检查)进行远程医疗特定考量。
临床怎么用
- 神经肿瘤外科门诊可考虑将远程医疗作为未来护理工具,但需关注各环节特定考量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The coronavirus 2019 (COVD-19) pandemic has drastically disrupted the delivery of neurosurgical care, especially for the already at-risk neuro-oncology population. The sudden change to clinic visits has rapidly spurned the implementation of telemedicine. A recommendation care paradigm of neuro-oncologic patients limited by telemedicine has not been reported. METHODS: A summary of a multi-institution experience detailing the potential benefits, pitfalls, and the necessary considerations to outpatient care of neurosurgical oncology patients. RESULTS: There are limitations and advantages to incorporating telemedicine into the outpatient care of neuro-oncology patients. Telemedicine-specific considerations for each step and stakeholder of the appointment (physician, patient, scheduling, previsit, imaging, and physical examination) are examined. CONCLUSIONS: Telemedicine, pushed to prominence during this COVID-19 pandemic, is a powerful and possibly preferential tool for the future of outpatient neuro-oncologic care.
引用
- Daggubati LC, Eichberg DG, Ivan ME, et al. Telemedicine for Outpatient Neurosurgical Oncology Care: Lessons Learned for the Future During the COVID-19 Pandemic. World Neurosurg. 2020. PMID: 32450309. doi:10.1016/j.wneu.2020.05.140
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。